Combined robot motor assistance with neural circuit-based virtual reality (NeuCir-VR) lower extremity rehabilitation training in patients after stroke: a study protocol for a single-centre randomised controlled trial.
Combined robot motor assistance with neural circuit-based virtual reality (NeuCir-VR) lower extremity rehabilitation training in patients after stroke: a study protocol for a single-centre randomised controlled trial.
复制标题
机器人运动辅助与基于神经回路的虚拟现实 (NeuCir-VR) 下肢康复训练相结合,用于中风后患者:单中心随机对照试验的研究方案
DOI:
10.1136/bmjopen-2022-064926
复制
发表时间:
2022-12-23
期刊:
影响因子:
2.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Improving lower extremity motor function is the focus and difficulty of post-stroke rehabilitation treatment. More recently, robot-assisted and virtual reality (VR) training are commonly used in post-stroke rehabilitation and are considered feasible treatment methods. Here, we developed a rehabilitation system combining robot motor assistance with neural circuit-based VR (NeuCir-VR) rehabilitation programme involving procedural lower extremity rehabilitation with reward mechanisms, from muscle strength training, posture control and balance training to simple and complex ground walking training. The study aims to explore the effectiveness and neurological mechanisms of combining robot motor assistance and NeuCir-VR lower extremity rehabilitation training in patients after stroke. This is a single-centre, observer-blinded, randomised controlled trial. 40 patients with lower extremity hemiparesis after stroke will be recruited and randomly divided into a control group (combined robot assistance and VR training) and an intervention group (combined robot assistance and NeuCir-VR training) by the ratio of 1:1. Each group will receive five 30 min sessions per week for 4 weeks. The primary outcome will be Fugl-Meyer assessment of the lower extremity. Secondary outcomes will include Berg Balance Scale, Modified Ashworth Scale and functional connectivity measured by resting-state functional MRI. Outcomes will be measured at baseline (T0), post-intervention (T1) and follow-ups (T2–T4). The trial was approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Traditional Medicine (Grant No. 2019–014). The results will be submitted to a peer-reviewed journal or at a conference. ChiCTR2100052133.
登录
查看更多内容
DOI:
10.1016/s0003-9993(95)80038-7
发表时间:
1995-01-01
影响因子:
4.3
作者:
JORGENSEN, HS;NAKAYAMA, H;OLSEN, TS
通讯作者:
OLSEN, TS
影响因子:
5.1
作者:
Kim, Ha Yeon;Shin, Joon-Ho;Lee, Stephanie Hyeyoung
通讯作者:
Lee, Stephanie Hyeyoung
影响因子:
2.2
作者:
Bart, Orit;Agam, Tami;Kizony, Rachel
通讯作者:
Kizony, Rachel
DOI:
10.23736/s1973-9087.17.04735-9
发表时间:
2018-06-01
影响因子:
4.5
作者:
Bergmann, Jeannine;Krewer, Carmen;Mueller, Friedemann
通讯作者:
Mueller, Friedemann
影响因子:
6.1
作者:
Deng YH;Dong LL;Zhang YJ;Zhao XM;He HY
通讯作者:
He HY